Skip to main content
. 2020 Mar 19;79(4):490–498. doi: 10.1136/annrheumdis-2019-216500

Figure 2.

Figure 2

Changes from baseline to week 24 in DSS (A), psoriasis disease activity (D) and composite disease activity indices (E). Proportion of responders at week 24 of DSS 20, 50 and 70 (B), LDI 20, 50 and 70 (C) and response indices (F). ACR, American College of Rheumatology response index; BSA, body surface area; CDAI, clinical disease activity index; CPDAI, composite psoriatic disease activity index; DSS, Dactylitis Severity Score; DAPSA, disease activity in psoriatic arthritis; DAS28 4v, Disease Activity Score four variables; LDI, Leeds Dactylitis Index; MDA, minimal disease activity; MTX, methotrexate; NAPSI, Nail Psoriasis Severity Index; PASDAS: Psoriatic Arthritis Disease Activity Score; PASI: Psoriasis Area and Severity Index; PsAJAI, Psoriatic Arthritis Joint Activity Index; PsARC, Psoriatic Arthritis Response Criteria; SDAI, simplified disease activity index. *p<0.05; **p<0.005; ***p<0.001.